Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lumenis gets antitrust case and questions from SEC (US Securities and Exchange Commission)

This article was originally published in Clinica

Executive Summary

Laser company Lumenis has had an antitrust and patent infringement claim slapped on it just days after receiving a request from the US Securities and Exchange Commission (SEC) for documents and information. Shares in the company fell by over 30% to around $9, although the company also had some good news in the form of an agreement to refinance a $100 million term loan and $71 million in convertible bonds.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064990

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel